Literature DB >> 11389867

Isolation and characterisation of dipeptidyl peptidase IV from Prevotella loescheii ATCC 15930.

Y Koreeda1, M Hayakawa, T Ikemi, Y Abiko.   

Abstract

A proline-specific dipeptidyl aminopeptidase, dipeptidyl peptidase IV (EC 3.4.14.5), was purified from a cell sonicate soluble fraction of Prevotella loescheii ATCC 15930 by sequential column chromatography. The molecular mass of the native enzyme was estimated as 160 kDa by high-pressure liquid gel filtration column chromatography and unheated sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The subunit molecular mass was 80 kDa when the enzyme was heated to 100 degrees C in the presence of 2-mercaptoethanol before SDS-PAGE, suggesting that the native enzyme consists of two identical subunits and is folded in 2% SDS. The optimum pH, with glycyl-prolyl-4-methyl-coumaryl-7-amide as the substrate, was 8.0; the isoelectric point was 5.2. Purified enzyme showed a strong preference for dipeptide substrates containing proline and, less efficiently, alanine in the P1 position. The enzyme was markedly inhibited by Cd(2+), Zn(2+), Hg(2+), Co(2+), and serine proteinase inhibitor di-isopropylfluorophosphate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389867     DOI: 10.1016/s0003-9969(00)00065-0

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  2 in total

1.  Effect of zinc and calcium ions on the rat kidney membrane-bound form of dipeptidyl peptidase IV.

Authors:  Hansel Gómez; Mae Chappé; Pedro A Valiente; Tirso Pons; María de Los Angeles Chávez; Jean-Louis Charli; Isel Pascual
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

2.  CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors.

Authors:  K Sato; U Aytac; T Yamochi; T Yamochi; K Ohnuma; K S McKee; C Morimoto; N H Dang
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.